manufacturing issues

FDA
Manufacturing

Novo plant issues may mean delays for Regeneron, Scholar Rock

The FDA has tagged Novo Nordisk's plant in Indiana with an OAI label, which is the most severe of its three inspection classifications.
Kevin Dunleavy Oct 13, 2025 3:48pm
FDA stop sign

FDA slams Ali Pharma with warning over porcine API production

Nov 1, 2023 9:05am
eyeball retinal diseases

FDA flags 'deficient' manufacturing standards at Global Pharma

Apr 4, 2023 8:35am
AstraZenecas headquarters

AstraZeneca still plans to seek U.S. approval of its COVID shot

Apr 21, 2021 2:20pm
B Braun IV bags

B. Braun commits $1B to expand in face of IV fluid shortages

May 15, 2019 9:50am
GSK building

GSK recalls respiratory inhalers from 9 markets outside the U.S.

Feb 22, 2018 8:05am